SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-12-052856
Filing Date
2012-02-10
Accepted
2012-02-10 17:02:51
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-Q d299107d10qa.htm 10-Q/A 692372
2 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 d299107dex311.htm EX-31.1 6693
3 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 d299107dex312.htm EX-31.2 6705
4 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 d299107dex321.htm EX-32.1 4494
5 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 d299107dex322.htm EX-32.2 4511
  Complete submission text file 0001193125-12-052856.txt   3006991

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lgnd-20110930.xml EX-101.INS 439115
7 XBRL TAXONOMY EXTENSION SCHEMA lgnd-20110930.xsd EX-101.SCH 13314
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lgnd-20110930_cal.xml EX-101.CAL 54245
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lgnd-20110930_def.xml EX-101.DEF 19783
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lgnd-20110930_lab.xml EX-101.LAB 146283
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lgnd-20110930_pre.xml EX-101.PRE 97693
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33093 | Film No.: 12593856
SIC: 2834 Pharmaceutical Preparations